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erythrocyte sedimentation rate, complete 
blood count, complete and fractional pro-
teinemia, serum calcium and urinary calci-
um, phosphorus, creatinine (with estimated 
glomerular filtration rate—eGFR), and al-
kaline phosphatase. However, second-level 
laboratory tests are indicated when in first-
level exams the clinical picture is associated 
IntroduCtIon
Multiple myeloma is rare under the age 
of 30 (less than 0.3%) and may be undiag-
nosed or characterized by a significant delay 
in diagnosis, which usually occurs at the first 
event of fracture [1]. Moreover, treatment 
outcomes in younger adults are better than 
those observed in older patient groups, thus 
confirming the importance of early detection 
in these pathologies.
The current guidelines recommend the 
use of both imaging (Dual-energy X-ray ab-
sorptiometry, DXA) and laboratory tests, in 
order to evaluate various conditions, among 
which osteoporosis is the common denomi-
nator. The minimum cost-effective group of 
tests to be performed in order to investigate 
the presence of occult metabolic disorders in 
adults at risk of falls and fractures or in case 
of suspected osteoporosis should include 
Why we describe this case
The described case report highlights the 
issue of evaluation of secondary osteopo-
rosis and osteoporosis in young patients, 
because the complications of these cases, 
too often misunderstood until the frac-
ture event, can be serious and the prog-
nosis is significantly related to the delay 
in the diagnosis
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Case report
Abstract
Multiple myeloma is rare in young patients and may be undiagnosed or characterized by a 
significant delay in diagnosis.
We report the association of stage I myeloma (according to Durie-Salmon classification) and 
osteoporosis in a 37-year-old male patient complaining of worsening pain in the spine. Pain 
attacks resulted in increases in blood pressure with hypertensive episodes. The investigations 
(on the basis of an unclear radiological picture and the presence of hypertensive state) led to the 
diagnosis of low grade osteoporosis. Since the young subject was symptomatic at the diagnosis, 
we continued evaluations on the basis of imaging data (DXA) and laboratory tests, revealing 
the presence of multiple myeloma. Clinical, laboratory, and therapeutic implications of this 
clinical case are discussed. 
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with abnormalities possibly suggestive of 
the disease: ionized calcium, thyroid-stim-
ulating hormone—TSH, serum parathyroid 
hormone—PTH, 25-OH-vitamin D, dexa-
methasone suppression test, total testoster-
one (in men), serum and urine immunofixa-
tion, serum ferritin, anti-transglutaminase 
antibodies, and serum tryptase levels [2]. 
Although secondary osteoporosis accounts 
for a small minority (< 5%) of the total cases 
of osteoporosis in women, it represents an 
important cause of disease in male patients, 
and may indicate the presence a serious ill-
ness, sometimes with poor prognosis (espe-
cially in case of delayed diagnosis).
In this case report, the assessment of mus-
culoskeletal and cardiovascular systems in a 
young male patient led to an early diagnosis 
of a potentially fatal disease.
CAse presentAtIon
A 37-year-old patient, construction work-
er, came to our hospital for pressure control 
and complaining about a pain localized in 
the dorsal and lumbar spine. Vital signs 
were within limits, except blood pressure—
BP = 140/100 mmHg. Pain was present on 
percussion of the spinous processes from 
5th to 7th, with a mild paresthesia in the 
right upper limb, reported to be present for 
many years. His recent blood count, thyroid 
function, renal, and lipid profile tests were 
all normal.
24-hour monitoring of the blood pressure 
showed “daytime diastolic blood pressure at 
upper limit of normal and occasional night-
time systolic and diastolic blood pressure 
levels slightly exceeding the limits, with 
preserved circadian rhythmicity”. Chest 
X-ray revealed a right-convex scoliosis, in 
the absence of pulmonary foci or pleural 
abnormalities. The patient started antihy-
pertensive therapy (ACE-inhibitor) and 
a regimen of NSAIDs, with poor blood 
pressure control and pain (Number Rating 
Scale—NRS = 4/10).
A new lumbar spine and pelvis X-ray 
showed hyperlucency of the lumbar spine 
with unscathed pelvis and a mild osteoporo-
sis framework, as evidenced by another DXA 
(the exam was performed privately, with a 
T-score =  -2.6 at the level of L2 vertebral 
body and a total T-score at the spine = -2.0). 
The radiological image did not show any ver-
tebral fracture. Analyzing the morphometry 
of the vertebral bodies, no significant decrease 
(as to fall within the definition of fracture) in 
the height of the vertebrae was detected 
(semi-quantitative method of H. K. Genant). 
At this stage, 1th level blood tests were per-
formed, showing normal levels, except the 
percentage of β2-globulins and γ-globulins, 
as reported in Table I and Figure 1.
Owing to the suspected monoclonality in 
β2 zone, immunofixation and other blood 
tests were performed, showing the results 
reported in Table II.
κ chains were absent, while the λ chains 
were present (3,67 g/l; normal values: 0.90-
2.10; Figure 2).
A fine needle aspiration of bone marrow 
was performed, finding plasma cells infil-
trate in 15% of the examined bone marrow. 
Multiple myeloma was staged according to 
Durie-Salmon staging and the New In-
ternational Staging System (stage 1). The 
patient was taken in charge by a multi-
disciplinary team formed by hematologists 
and orthopedists to carry on the diagnostic 
(scintigraphy) and therapeutic management 
(careful observation with seriated controls 
over time; possible preventive osteosynthe-











Albumin 4.7 3.5-5 56.8 55.8-66.1
α1-globulins 0.23 0.2-0.4 3.5 2.9-4.9
α2-globulins 0.63 0.4-0.8 9.8 7.1-11.8
β1-globulins 0.43 0.6-1 6 4.7-7.2
β2-globulins 1.15 0.6-1 14.3 3.2-6.5
γ-globulins 0.70 0.9-1.4 9.6 11.1-18.8
Total proteins 7.6 - - -
A/G ratio 1.43 1.10-2.40 - -
table I. Results about 
proteins in the blood 
tests (percentage and 
absolute levels)




test showing an 
electrophoretic pattern 
of proteins with 
anomalies
parameter detected level normal levels
IgA (mg/dl) 1144 63-484
IgG (mg/dl) 727 540-1822
IgM (mg/dl) 73 33-293
β2-microglobulin (mg/l) 2.32 0.97-2.64
Total serum calcium 
concentration (mg/dl)
9 (correct calcium 8.79) 8.5-10.5
table II. Results from 
immunofixation and 
other blood tests
Figure 2. Results from 
electrophoretic test, 
highlighting an increase 
in immunoglobulin A
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dIsCussIon
Multiple myeloma is a malignant tumor 
arising from plasma cells, frequently with 
bone involvement (including vertebral bodies 
and pelvis). Solitary lesions without systemic 
involvement may remain silent for many 
years, and often diagnosis is occasional: in 
this case, our diagnosis was due to hyperten-
sion (hyperviscosity?) and algic issues, the 
latter being difficult to investigate, because 
of the patient’s scoliosis and work history.
The electrophoretic test (among the rou-
tine tests for the evaluation of osteoporosis) 
put in evidence a peak with migration (seen 
at lower frequency) in the β zone, with a IgA 
peak in the pre-γ-area. Generally, altered im-
munoglobulins tend to associate with altera-
tions in calcium metabolism: hypercalcemia, 
which is absent in this case, is found in about 
30-40% of patients. Perhaps, our patient was 
the bearer of a previously unidentified and 
unstudied or unfollowed monoclonal gam-
mopathy of uncertain significance (MGUS) 
over time, already with initial bone damage 
(but the patient was not able to report tests 
or previous diagnosis of this condition) [3,4]. 
The pain after spine percussion was an im-
portant warning signal that led to a deep-
ening of diagnostic investigation. However, 
back pain is a common sign and fortunately 
most cases are due to benign causes. Anyway, 
serious causes such as cancer, infection, and 
even fractures must been considered [5]. As 
in the scenarios described in the literature, 
unexplained changes in bone mineral density 
– as in the present case – may trigger a more 
extensive evaluation, including the search for 
monoclonal components [6].
ConClusIons
Unquestionably osteoporosis in young in-
dividuals is less frequent than in adults and 
the elderly. But in this population group, the 
development of osteoporosis is often asso-
ciated with secondary causes [7,8]. In fact, 
almost 50% of young people with osteopo-
rosis have diseases or therapies related to the 
development of this disorder.
In order to rule out secondary causes of os-
teoporosis, laboratory studies should be ex-
tensive. Therefore, it is important to perform 
blood chemistry tests in all patients with 
osteoporosis or a recent clinical fracture. If 
necessary, additional tests can be performed.
National and international guidelines are 
focused on the diagnosis of secondary os-
teoporosis in the field of differential diag-
nosis with postmenopausal and senile forms 
[9,10]. Recommendations are less accurate 
about osteoporosis in the youth and even 
more so about secondary causes of osteo-
porosis in young patients.
Considering that prevention plays a key 
role in reducing the consequences of serious 
diseases, the laboratory plays an even more 
important role. Laboratory studies may 
show potentially reversible abnormalities 
that must be assessed and corrected, if possi-
ble, before starting pharmacological therapy, 
or silent secondary osteoporosis, requiring 
other types of treatment. In fact, secondary 
osteoporosis has a different etiology and 
can evolve asymptomatically until obvious 
signs of fracture or osteoporosis emerge, so 
that many subjects in the young adult age 
or adult but not elderly individuals may es-
cape the assessments because for a long time 
they are considered healthy subjects, at least 
until the time of the first event of fracture 
[11,12]. Therefore, the prompt recognition 
of secondary osteoporosis may have sig-
nificant repercussions both on the patient’s 
quality of life and the quoad vitam prognosis.
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Key points
 y The presence of pain on percussion of spinous processes should be a warning signal even in 
young patients with predisposing factors to back pain
 y Secondary osteoporosis has a different etiology as compared to primary osteoporosis, and 
can evolve asymptomatically until the first event of fracture
 y Laboratory studies play a key role in the diagnosis
 y Secondary osteoporosis may be due to multiple myeloma
 y Multiple myeloma is rare under the age of 30 and may be undiagnosed or characterized by 
a significant delay in diagnosis. A timely diagnosis is crucial in this life-threatening disease
